Karnataka Gets a Boost in Healthcare: Nikhita Laboratories Announces ₹15 Crore Bulk Drug Project

Nikhita Laboratories is embarking on a significant endeavor with its Bulk Drugs & Intermediates Project in Kadechur, Kalaburagi, Karnataka. With an investment of 15 crores, this project signifies the company's commitment to the pharmaceutical industry. The project aims to produce 104.7 tons per month of bulk drugs and intermediates, meeting the increasing demand for essential pharmaceutical ingredients.

Situated in Kadechur, Kalaburagi, Karnataka, the project benefits from its strategic location within a growing pharmaceutical hub. The region's supportive infrastructure and skilled workforce provide Nikhita Laboratories with the necessary resources to establish a successful manufacturing facility. Additionally, the proximity to key transportation routes ensures efficient distribution of products to domestic and international markets.

The Bulk Drugs & Intermediates Project incorporates advanced manufacturing technologies and stringent quality control measures to ensure the production of high-quality pharmaceutical ingredients. Nikhita Laboratories is committed to adhering to international quality standards and regulatory requirements, ensuring the safety and efficacy of its products for use in pharmaceutical formulations.

Sustainability is a key focus of the project, with Nikhita Laboratories implementing eco-friendly practices and resource-efficient processes. The company aims to minimize environmental impact through the responsible use of resources, waste reduction initiatives, and energy-efficient manufacturing practices. By prioritizing sustainability, Nikhita Laboratories aims to contribute positively to the environment and local community.

News by Rahul Yelligetti